JBC Papers in Press. Published on February 27, 2019 as Manuscript RA118.005831 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.RA118.005831 WFIKKN2 follistatin domain structure Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11 Jason C. McCoy1, Ryan G. Walker1,#, Nathan H. Murray1,$, Thomas B. Thompson1,*. 1From the department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, College of Medicine, Cincinnati, Ohio 45267. Running Title: WFIKKN2 Follistatin domain structure. #Present address: Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, MA 02138 Downloaded from $Present address: Department of Biochemistry, University of Wisconsin–Madison, Madison, WI 53706, USA *To whom correspondence should be addressed: Thomas B. Thompson: Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati OH 45267. http://www.jbc.org/
[email protected]; Tel. (513)-558-4517 Keywords: GDF8, Myostatin, GDF11, WFIKKN, follistatin, antagonism, X-ray crystallography, structural biology, tissue homeostasis, muscle development at University of Cincinnati/Medical Center Libraries on March 7, 2019 Abstract follistatin and FSTL3 revealed differences in both Growth differentiation factor 8 (GDF8), the FSD structure and position of residues within a.k.a. myostatin, and GDF11 are closely related the domain that are important for ligand members of the transforming growth factor β (TGF- antagonism. Taken together, our results indicate β) family. GDF8 strongly and negatively regulates that both WFIKKN and follistatin utilize their FSDs skeletal muscle growth, and GDF11 has been to block the type II receptor but do so via different implicated in various age-related pathologies such binding interactions.